Announcements Trials
Browse Landscape

Phase

Phase 3 5Phase 1 1

Status

Terminated 6Completed 5Withdrawn 1

Sponsor Class

INDUSTRY 6

Study Type

Interventional 6

Sponsor

Conditions

Leiomyoma 6Menorrhagia 3

Interventions

pembrolizumab 184Carboplatin 130Paclitaxel 123Gemcitabine 122Docetaxel 96Cyclophosphamide 89Nivolumab 88Cisplatin 87Rituximab 71Dexamethasone 68Pemetrexed 64Bevacizumab 64Capecitabine 60atezolizumab 54fludarabine 49Azacitidine 49Fluorouracil 48130-nm albumin-bound paclitaxel 43venetoclax 41Trastuzumab 41Irinotecan 41Cetuximab 40Leucovorin 36Ipilimumab 36Erlotinib Hydrochloride 34Fulvestrant 32Cytarabine 32avelumab 31Oxaliplatin 31Albumin-Bound Paclitaxel 31

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Terminated × INDUSTRY × vilaprisan × Clear all
NCT03194646 2025-07-28

ASTEROID 6

Bayer

Phase 3 Terminated
1,272 enrolled 16 charts

Leiomyoma

NCT03240523 2024-10-18

ASTEROID 5

Bayer

Phase 3 Terminated
766 enrolled

Leiomyoma

NCT03400943 2023-05-03

Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (ASTEROID 3)

Bayer

Phase 3 Terminated
93 enrolled 19 charts

Leiomyoma, Menorrhagia

NCT03476928 2022-07-08

ASTEROID 8

Bayer

Phase 3 Terminated
153 enrolled

Leiomyoma, Menorrhagia

NCT03400956 2022-06-30

Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (ASTEROID 4)

Bayer

Phase 3 Terminated
103 enrolled 18 charts

Leiomyoma, Menorrhagia

NCT03342859 2021-01-06

Mode of Action Study of Vilaprisan and Ulipristal Acetate in Patients With Uterine Fibroids for Whom Surgery is Planned

Bayer

Phase 1 Terminated
10 enrolled

Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡